Comparison of baseline HbA1c (a), diabetes duration (b) and C-peptide (c) in ‘responders’ and ‘non responders’ to GLP-1A defined by combined outcome or baseline adjusted HbA1c change (regression residuals).

<p>Responders n = 38, non responders n = 131.</p>